The contractor shall determine the antiviral inhibitory activity and cytotoxicity of test molecules against respiratory viruses using the specified test method to identify active test molecules for…
Ended Awarded Last action
- Contract number
- 75N93020F00001
- Awardee
-
Utah State University UEI SPE2YDWHDYU4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $354,191
Award facts
- Contract value 100% obligated
- $354,191.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Logan, UT 84322, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$559 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $354,750 |
About this award
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded Utah State University a $354,191 firm fixed price delivery order against the In Vitro Assessments of Antimicrobial Activity master IDIQ contract. Under this order, USU will determine the antiviral inhibitory activity and cytotoxicity of test molecules against respiratory viruses using specified test methods to identify actively compounds for further investigation. The work will be performed in Logan, Utah over a one year period ending in June 2021. This delivery order supports NIH/NIAID's efforts to develop antiviral therapies and provides USU the opportunity to leverage its expertise in virology testing towards this important public health goal.
Description
The contractor shall determine the antiviral inhibitory activity and cytotoxicity of test molecules against respiratory viruses using the specified test method to identify active test molecules for further investigation.
Quick answers
Who was awarded contract 75N93020F00001?
75N93020F00001 was awarded to Utah State University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 26, 2020.
How much is contract 75N93020F00001 worth?
The government has obligated $354,191 on 75N93020F00001.
Is contract 75N93020F00001 an order under another contract?
Yes. 75N93020F00001 is a delivery order under 75N93019D00021, an indefinite delivery contract, on In Vitro Assessments of Antimicrobial Activity (IVAAA).
Was contract 75N93020F00001 competed?
The extent of competition for 75N93020F00001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award